$146.27 +1.71 (1.18%) Biomarin Pharmaceutical Inc - NASDAQ

Jul. 31, 2015 | 04:00 PM
Key Statistics
Last Trade: 146.27
Trade Time: Jul 31 04:00 PM Eastern Daylight Time
Change: +1.71 (1.18%)
Prev Close: 144.56
Open: 145.44
Bid: 146.27
Ask: 146.31

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 29.00M +0.92%
CTLT Catalent Inc 15.80M +2.50%
MRK Merck & Co Inc 8.75M +0.75%
BMY Bristol-Myers Squibb Co 7.96M +1.83%
SGYP Synergy Pharmaceuticals Inc 7.32M +6.17%

BMRN Stock Analysis

Partner Headlines

  1. BioMarin Gets Price Target Hike On Pipeline Strength

    IBD | Jul. 8, 2015 | 12:12PM EST
  2. 2 DMD drugs make progress

    IBD | Jun. 29, 2015 | 18:45PM EST
  3. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  4. Baird Downgrades BioMarin Pharmaceutical To Neutral

    Benzinga | Jun. 19, 2015 | 10:31AM EST
  5. Benzinga's Volume Movers

    Benzinga | Jun. 19, 2015 | 10:31AM EST
  6. Benzinga's Top Downgrades

    Benzinga | Jun. 19, 2015 | 10:08AM EST
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!